Y-mAbs Therapeutics (YMAB) Projected to Post Earnings on Tuesday
Y-mAbs Therapeutics (NASDAQ:YMAB – Get Free Report) is expected to be posting its quarterly earnings results before the market opens on Tuesday, March 4th. Analysts expect Y-mAbs Therapeutics to post earnings of ($0.13) per share and revenue of $26.70 million for the quarter. Persons that are interested in participating in the company’s earnings conference call […]
Y-mAbs Therapeutics (NASDAQ:YMAB – Get Free Report) is expected to be posting its quarterly earnings results before the market opens on Tuesday, March 4th. Analysts expect Y-mAbs Therapeutics to post earnings of ($0.13) per share and revenue of $26.70 million for the quarter. Persons that are interested in participating in the company’s earnings conference call […]
